Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapy
The drug company Atai Life Sciences is spending millions to research the compound, and congressional lawmakers from both parties have been pushing the government to promote ibogaine research for substance abuse, post-traumatic stress disorder and other mental health problems. For Dr. Deborah Mash, a professor of neurology at the University of Miami who began studying…